Dynamics of the COVID -19 Related Publications
Author:
Sarkar BiplabORCID, Munshi AnusheelORCID, Ghosh BhaswarORCID, Ganesh TharmarnadarORCID, Manikandan ArjunanORCID, Biswal Subhra Singhdha, Sahid Tanweer, Rajagopalan B, Snegupta Sinjini, Raychaudhuri Sandipan, Bhattacharya Jibak, Gazi Mahasin, De Arundhati, George Kirubha, Ghosh Tanmay, Akhtar Jawed, Mondal Sourav, Mukherjee Mukti, Gupta RosalimaORCID, Roy Soumya, Jassal KananORCID, Rastogi Khushboo, Bansal Kanika, Chatterjee Prasenjit, Biswas Litan Naha, Bondopadhay Shymasish, Pradhan AnirudhORCID, Mohanti Bidhu KalyanORCID
Abstract
AbstractBackgroundThis study aims to analyze the dynamics of the published articles and preprints of Covid-19 related literature from different scientific databases and sharing platforms.MethodsThe PubMed, Elsevier, and Research Gate (RG) databases were under consideration in this study over a specific time. Analyses were carried out on the number of publications as (a) function of time (day), (b) journals and (c) authors. Doubling time of the number of publications was analyzed for PubMed “all articles” and Elsevier published articles. Analyzed databases were (1A) PubMed “all articles” (01/12/2019-12/06/2020) (1B) PubMed Review articles (01/12/2019-2/5/2020) and (1C) PubMed Clinical Trials (01/01/2020-30/06/2020) (2) Elsevier all publications (01/12/2019-25/05/2020) (3) RG (Article, Pre Print, Technical Report) (15/04/2020–30/4/2020).FindingsTotal publications in the observation period for PubMed, Elsevier, and RG were 23000, 5898 and 5393 respectively. The average number of publications/day for PubMed, Elsevier and RG were 70.0 ±128.6, 77.6±125.3 and 255.6±205.8 respectively. PubMed shows an avalanche in the number of publication around May 10, number of publications jumped from 6.0±8.4/day to 282.5±110.3/day. The average doubling time for PubMed, Elsevier, and RG was 10.3±4 days, 20.6 days, and 2.3±2.0 days respectively. In PubMed average articles/journal was 5.2±10.3 and top 20 authors representing 935 articles are of Chinese descent. The average number of publications per author for PubMed, Elsevier, and RG was 1.2±1.4, 1.3±0.9, and 1.1±0.4 respectively. Subgroup analysis, PubMed review articles mean and median review time for each article were <0|17±17|77> and 13.9 days respectively; and reducing at a rate of-0.21 days (count)/day.InterpretationAlthough the disease has been known for around 6 months, the number of publications related to the Covid-19 until now is huge and growing very fast with time. It is essential to rationalize the publications scientifically by the researchers, authors, reviewers, and publishing houses.FundingNone
Publisher
Cold Spring Harbor Laboratory
Reference19 articles.
1. https://coronavirus.jhu.edu/map.html (accessed on 31-05-2020) 2. https://www.sciencemag.org/news/2020/05/scientists-are-drowning-covid-19-papers-can-new-tools-keep-them-afloat 3. Beigel JH , Tomashek KM , Dodd LE , Mehta AK , Zingman BS , Kalil AC , Hohmann E , Chu HY , Luetkemeyer A , Kline S , Lopez de Castilla D. Remdesivir for the treatment of Covid-19—preliminary report. New England Journal of Medicine. 2020 May 22. 4. Wang Y , Zhang D , Du G , Du R , Zhao J , Jin Y , Fu S , Gao L , Cheng Z , Lu Q , Hu Y. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet. 2020 Apr 29. 5. Tselios K , Skendros P. Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence. Eur J Rheumatol XX April. 2020 May 15:10–5152.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|